BioHealth News
Cartesian Reports Positive Phase 2b Results for Descartes-08 in Myasthenia Gravis and Previews Phase 3 Trial
FREDERICK, Md., Dec. 03, 2024 (GLOBE…
Read MoreGaithersburg’s Shuttle Pharma Begins Phase 2 Trial of Ropidoxuridine for Glioblastoma at UVA Cancer Center
GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE…
Read MoreRevolutionizing Respiratory Care: Linshom Medical’s Journey to Innovation and Recognition on BioTalk
In this episode of BioTalk, host Rich…
Read MoreUniversity of Maryland Institute for Health Computing Celebrates Second Anniversary
Uncovering bias in AI models used…
Read MoreArlington Capital Partners Acquires TEAM Technologies
Washington, D.C. – November 25, 2024…
Read MoreMTD: Michelle Tarver faces challenges as the FDA’s new CDRH leader. But patient groups, industry are optimistic.
Michelle Tarver, the new leader of…
Read MoreTransforming Emergency Medicine: Dr. Eric Edwards and MedPhlow’s Life-Saving Innovations on BioTalk
In this episode of BioTalk with…
Read MoreBARDA Launches SPARK Hub Prize Challenge to Advance Pediatric Medical Countermeasures
The Biomedical Advanced Research and Development…
Read MoreTearSolutions, Inc. Secures $3M Series B Funding
CHARLOTTESVILLE, Va., Nov. 21, 2024 (GLOBE…
Read MoreNaviMed Capital Closes Fund III at $450 Million Hard Cap
Firm Remains Focused on Partnering with…
Read MorePotomac’s Versant Ventures Unveils Pep2Tango Therapeutics Inc.
POTOMAC, Md.--(BUSINESS WIRE)--Versant Ventures today announced…
Read MoreBaltimore Banner: Exciting new Concept Capital Pitch Competition at TEDCO’s Entrepreneur Expo
There are several keys to successful…
Read MoreIsrael’s Biolojic Design Joins Johnson & Johnson Innovation – JLABS @ Washington
REHOVOT, Israel and WASHINGTON, Nov. 19,…
Read MoreMaryland’s IonQ to Advance Hybrid Quantum Computing with New Chemistry Application and NVIDIA CUDA-Q
November 18, 2024 01:30 PM Eastern…
Read MoreNIH Office of Technology Transfer Seeks Deputy Director to Lead Licensing Operation
The NIH Office of Technology Transfer…
Read More